(Q45361114)

13 December 2017

Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. (English)

1 reference

13 December 2017

0 references

0 references

1 reference

Carmen Bozic

1

1 reference

13 December 2017

Sandra Richman

2

1 reference

13 December 2017

Tatiana Plavina

3

1 reference

13 December 2017

Amy Natarajan

4

1 reference

13 December 2017

James V Scanlon

5

1 reference

13 December 2017

Meena Subramanyam

6

1 reference

13 December 2017

Alfred Sandrock

7

1 reference

13 December 2017

Gary Bloomgren

8

1 reference

13 December 2017

1 November 2011

1 reference

13 December 2017

1 reference

13 December 2017

70

1 reference

13 December 2017

5

1 reference

13 December 2017

742-750

1 reference

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

13 December 2017

1 reference

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

21 January 2018

1 reference

Anti-JC virus antibodies: implications for PML risk stratification

21 January 2018

1 reference

Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.

21 January 2018

1 reference

Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans

21 January 2018

1 reference

Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.

21 January 2018

1 reference

Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients

21 January 2018

1 reference

Seroepidemiology of human polyomaviruses

21 January 2018

1 reference

Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition

21 January 2018

1 reference

Characterization of JC human polyomavirus infection in a Portuguese population.

21 January 2018

1 reference

Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy

21 January 2018

1 reference

JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab

21 January 2018

1 reference

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

21 January 2018

1 reference

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.

21 January 2018

1 reference

Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs

21 January 2018

1 reference

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

21 January 2018

1 reference

Assay design and sample collection can affect anti-John Cunningham virus antibody detection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22606

1 reference

13 December 2017

1 reference